SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Cardiovascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Neukamm, B.
Right arrow Articles by Krieger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neukamm, B.
Right arrow Articles by Krieger, J. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research: Local TAT-p27Kip1 Fusion protein inhibits cell proliferation in rat Carotid arteries

Birgit Neukamm

Heart Institute (InCor)/LIM 13, University of Sao Paulo Medical School, Sao Paulo, Brazil

Ayumi A. Miyakawa

Laboratory of Genetic and Molecular Cardiology, Heart Institute (InCor), University of Sao Paulo Medical School, Av. Dr. Eneas C. Aguiar, 44 - 10 andar, 05403-000 Sao Paulo - SP - Brazil, ayumi.miyakawa{at}incor.usp.br

Sandra Y. Fukada

Department of Pharmacology, School of Medicine of Ribeirao Preto, USP, Ribeirao Preto SP, Brazil

Claudia R. de Andrade

Department of Pharmacology, School of Medicine of Ribeirao Preto, USP, Ribeirao Preto SP, Brazil

Fernando P. Pacheco

Heart Institute (InCor)/LIM 13, University of Sao Paulo Medical School, Sao Paulo, Brazil

Thaís G. da Silva

Heart Institute (InCor)/LIM 13, University of Sao Paulo Medical School, Sao Paulo, Brazil

Leandra N. Z. Ramalho

Department of Pathology, School of Medicine of Ribeirao Preto, USP, Ribeirao Preto SP, Brazil

Ana Maria de Oliveira

Department of Pharmacology, School of Medicine of Ribeirao Preto, USP, Ribeirao Preto SP, Brazil

Jose E. Krieger

Laboratory of Genetic and Molecular Cardiology, Heart Institute (InCor), University of Sao Paulo Medical School, Av. Dr. Eneas C. Aguiar, 44 - 10 andar, 05403-000 Sao Paulo - SP - Brazil, krieger{at}incor.usp.br

Introduction: p27Kip1 is a cyclin kinase inhibitor that induces cell cycle arrest. In this study, the efficacy of fusion protein TAT- p27Kip1 to inhibit cell proliferation in rat perivascular injured carotid arteries was tested.

Methods: The cDNA of p27Kip1 and GFP (green fluorescein protein) fused to the TAT epitope, which allows cell penetration, yielded TAT-p27 Kip1 and TAT-GFP fusion proteins. In vitro biological activity on cell proliferation was evaluated by [3H] thymidine DNA incorporation in rabbit aortic endothelial cells (REC). An in vivo model used a silicone collar filled with saline positioned around the carotid vessel for 14 days to produce an increased adventitia cross-sectional area.

Results: TAT-p27Kip1 inhibited REC proliferation in vitro using either 100, 200, and 500 nM compared to control (88.2 ± 4.4, 81.3 ± 7, 71.9 ± 4.2 vs. 100 ± 6.7%, N = 3, respectively, p < 0.05). This response was stable for purified proteins stored at -20•C for at least 23 days. In vivo , TAT-p27Kip1 solution reduced adventitia cross-sectional area in a dose-dependent manner compared to TAT-GFP (area in mm2 — TAT-p27Kip1: 200 nM, 0.160 ± 0.018; 500 nM, 0.050 ± 0.005 vs. TAT-GFP: 500 nM, 0.595 ± 0.066 vs. the contralateral: 0.047 ± 0.005, N = 7, p < 0.01).

Conclusion: Taken together, these results provide evidence that TAT-p27Kip1 can inhibit vascular cells proliferation. It is the first successful demonstration that the cell permeable TAT-p27Kip1 has potential as a vascular anti-proliferative agent.

Key Words: p27Kip1 • TAT-fusion protein • vascular injury

Therapeutic Advances in Cardiovascular Disease, Vol. 2, No. 3, 129-136 (2008)
DOI: 10.1177/1753944708090170


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement